GeoVax Labs, Inc. (GOVX): Nasdaq/NYSE listing notice — GeoVax gets Nasdaq extension to Dec 4, 2023 for $1 bid price rule

GeoVax Labs, Inc.

Received Dec 9, 2022 deficiency letter for bid price below $1 for 30 consecutive days.
Nasdaq granted 180-day extension until December 4, 2023 to regain compliance.
Must close at or above $1 per share for 10 consecutive business days to comply.
If not met by deadline, Nasdaq will initiate delisting; company may appeal.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GeoVax Labs, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

June 8, 2023, the Company received written notification from Nasdaq granting the Company’s request. The Company now has until December 4, 2023 to meet the Bid Price Requirement (the “Compliance Date”). The grant of the extension by Nasdaq has no effect on the listing of the Company’s shares, which will continue to be listed on the Nasdaq Capital Market under the symbol “GOVX.” If at any time prior to the Compliance Date, the bid price of the Company's common stock closes at, or above, $1.00 per share for a minimum of ten (10) consecutive business days Nasdaq will provide the Company with writt

View on SEC.gov

Browse all listing & compliance notices →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-017081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.